Dr. Kevin Hill -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Kevin Hill, a General Surgery physician based in City, VA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Kevin Hill has received $29.54 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Kevin Hill
- Medical Specialty: General Surgery
- Practice Location: City, VA, Virginia
- NPI Number: 1335206905
- Transparency Score: 95/100
- Payment Records Span: 2024-06-12 to 2024-06-12
Payment Summary
Dr. Kevin Hill has received a total of $29.54 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $29.54 per transaction.
- Total Payments Received: $29.54
- Number of Transactions: 1
- Average Payment: $29.54
- Transparency Score: 95/100 -- This score reflects the overall payment profile relative to peers in General Surgery. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
- Drugs/Devices Referenced: 1 distinct products
Payment Breakdown by Category
The following table shows how Dr. Kevin Hill's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Food & Beverage | $29.54 | Meals and refreshments during sales visits, meetings, and events |
The largest payment category for Dr. Kevin Hill is Food & Beverage, accounting for 100% ($29.54) of total pharmaceutical payments received. This is the most common type of pharmaceutical payment and typically involves meals provided during sales representative visits.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Kevin Hill. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| Johnson & Johnson | $29.54 | 1 |
Dr. Kevin Hill has a financial relationship with Johnson & Johnson, receiving $29.54 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
Drugs and Medical Devices Referenced in Payments
The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Kevin Hill. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.
- Kisqali -- Referenced in payment records from pharmaceutical companies to Dr. Kevin Hill
The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Kevin Hill's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Dr. Kevin Hill, a General Surgeon in City, VA, has a pharmaceutical payment profile characterized by minimal engagement. With a total of $29.54 in payments from one transaction, Dr. Hill's financial relationship with the pharmaceutical industry is exceptionally low. This amount is significantly below the typical payment volumes observed among General Surgeons nationwide. While specific peer group averages can fluctuate, it is common for surgeons in this specialty to receive payments ranging from hundreds to thousands of dollars annually, often for activities like consulting, speaking engagements, or research collaborations. The solitary payment received by Dr. Hill, amounting to $29.54, was from Johnson & Johnson and was categorized as a meal. This suggests a very limited, almost negligible, interaction with pharmaceutical companies. The pattern of payments does not indicate routine professional activity beyond a minor courtesy; rather, it points to an almost complete absence of substantial financial ties. Such a low volume of payments generally does not raise concerns about undue influence on clinical decision-making or prescribing habits. For patients, this minimal financial interaction means that Dr. Hill's treatment recommendations are likely based on established medical evidence and patient-specific needs, rather than on incentives from drug manufacturers. Patients can feel confident that their care is not being shaped by financial entanglements with the pharmaceutical industry. The transparency of these payments, even at this minimal level, allows for informed patient understanding and trust in the doctor-patient relationship.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Kevin Hill is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
When considering your doctor's relationships with pharmaceutical companies, it's important to remember that not all payments are inherently problematic. Many interactions, such as educational events or consulting on new therapies, can be beneficial for keeping doctors informed. However, significant or frequent payments, especially for meals or speaking engagements that seem excessive, can sometimes raise questions about potential influence on prescribing habits. At your next appointment, you might consider asking your doctor if they have any financial relationships with pharmaceutical companies whose medications they prescribe. A red flag might be if a doctor seems overly enthusiastic about a particular drug without a clear clinical justification, or if their prescribing patterns significantly deviate from standard guidelines without explanation. Normal relationships often involve doctors participating in advisory boards, speaking at medical conferences, or engaging in clinical trials, which are typically well-documented. Concerning patterns might include frequent, small payments for meals that seem to encourage brand-name prescribing or a lack of transparency about these relationships. Ultimately, evaluate your doctor's prescribing patterns against established medical guidelines and consider if their recommendations align with your best interests and evidence-based medicine.
Peer Comparison: How Dr. Kevin Hill Compares to Other General Surgery Physicians
Dr. Kevin Hill's total pharmaceutical payments of $29.54 are exceptionally low when compared to the average for General Surgery. While averages vary, many General Surgeons receive payments in the hundreds or thousands of dollars annually for various professional activities. Dr. Hill's profile, with a single meal payment, places him at the extreme low end of the spectrum, indicating minimal financial interaction with the pharmaceutical industry.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Kevin Hill in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| Johnson & Johnson | $29.54 | meals | Kisqali | 2024-06-12 | Not Assessed |
Frequently Asked Questions About Dr. Kevin Hill's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
Is Dr. Kevin Hill taking too much pharma money?
No, Dr. Kevin Hill is not taking a significant amount of pharmaceutical money. His total payments are only $29.54, which is exceptionally low for a General Surgeon. This minimal amount, consisting of a single meal payment, suggests virtually no financial ties to the industry. Compared to the typical payment volumes seen in his specialty, Dr. Hill's profile indicates a strong independence from pharmaceutical influence, which is generally viewed positively from a patient's perspective.
What pharma companies pay Dr. Kevin Hill?
Dr. Kevin Hill receives payments from one pharmaceutical company: Johnson & Johnson, totaling $29.54. This represents his entire reported pharmaceutical payment volume.
Should I switch doctors because of pharma payments?
A single, small payment of $29.54 for a meal from Johnson & Johnson is highly unlikely to be a reason to switch doctors. This amount is negligible and does not suggest any undue influence. You should only consider switching doctors if you have concerns about the quality of care, communication, or if you observe a pattern of prescribing that seems questionable and is not well-explained, especially if the doctor is unwilling to discuss their prescribing rationale or potential conflicts of interest.
What kinds of payments does this doctor receive?
Dr. Kevin Hill receives payments exclusively in the form of meals. His total reported payments consist of a single instance of a $29.54 meal paid for by Johnson & Johnson. There are no reported payments for consulting, speaking, travel, research, or ownership interests.
How do these payments compare to other General Surgery?
Dr. Hill's payments of $29.54 are significantly lower than the average for General Surgery. While specific averages vary, many surgeons in this field receive payments in the hundreds or thousands of dollars annually for activities like consulting, speaking, or research. His profile is at the extreme low end, indicating minimal financial engagement with pharmaceutical companies.
Do pharma payments affect prescribing quality?
Research suggests that even small payments can subtly influence physician prescribing behavior, often unconsciously. However, the impact is generally correlated with the volume and nature of payments. Dr. Hill's minimal payment of $29.54 is unlikely to have a discernible impact on his prescribing quality. For doctors with substantial payment histories, it's prudent for patients to be aware and discuss prescribing choices, ensuring they align with evidence-based practices and individual needs.
How can I verify this payment data?
You can verify this payment data directly through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. Visit the official CMS Open Payments website, search for Dr. Kevin Hill using his name and NPI (1335206905), and you can review the detailed records of payments reported by pharmaceutical and medical device companies.
Understanding This Doctor Payment Report
This transparency report for Dr. Kevin Hill is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. General Surgery physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Kevin Hill's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Kevin Hill and all other physicians can be accessed at the official CMS Open Payments website.
Related Resources
- General Surgery Specialty Payment Data -- See payment patterns for all general surgery physicians
- Virginia Physician Payments -- Browse pharmaceutical payments to physicians in Virginia
- General Surgery Physicians in Virginia -- Compare Dr. Kevin Hill to peers in the same state and specialty
- Johnson & Johnson Payment Profile -- View all payments made by Dr. Kevin Hill's largest pharmaceutical partner
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Kevin Hill's NPI (1335206905) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.